Teva Pharmaceuticals and IBM Partner to look for data health solutions

It has been announced by IBM Watson Health and Teva Pharmaceutical Industries Ltd. that Teva has been chosen as its first Foundational Life Sciences Partner for the Watson Health Cloud. With this, Teva will be the first global pharmaceutical company to use the power of the Watson Health Cloud to help patients and healthcare providers across the world.

Teva has selected the IBM Watson Health Cloud as a preferred cognitive computing platform and is looking forward to come up with solutions to help millions of individuals in the world with complex and chronic health conditions like pain, asthma, migraine and neurodegenerative diseases. Additionally, a joint Teva-IBM Research team will be setting up Big Data and machine learning technology in order to come up with disease models and new therapeutic solutions.

According to Guy Hadari, SVP and CIO for Teva Pharmaceutical Industries Ltd, Teva is looking at e-health evolution and emphasizes meeting emerging patients' requirements and the IBM Watson Health Cloud offers a solid foundation on which it is possible to do so.

According to Hadari, "By building on the Watson Health Cloud, we believe Teva will be in a unique position to put the best information and insights in the hands of physicians, care teams and patients, to empower treatment optimization". Hadari added that individuals and populations dealing with acute and chronic conditions will also be benefited.

Watson is a revolutionary cognitive computing platform, which corresponds to advanced computing that is based on its capability of interacting in natural language and process huge amounts of Big Data.